Allergies are currently skyrocketing. In this current day and age it is reckoned that one in five people have an allergy.
Previously there had been very little knowledge of what caused allergies and how to combat them. The aversion strategy had been the main form of attack against the prevalence of an adverse immune attack. However, this has seemingly not been the best approach.
Immunotherapy techniques have been developed to wean the body to accepting immunogenic samples by queuing the response to them and sensitising the body to the exposure of allergens. The field is very much in its infancy with a range of exciting discoveries giving hope to people suffering from
allergies.
However, there is a great lack of understanding on matters of how to administer therapy in an effective manner and how to increase patient compliance.
The second annual
Allergies conference takes place on the 8th-9th of July 2015 at the Marriott Regents Park, London and will introduce the audience to a range of new developments in the field and allow for an understanding of where the field of allergy therapeutics is going.
The agenda focuses on a range of hot topics:
- Development of novel vaccines and adjuvants for immunotherapy
- Regulation and clinical trials for paediatric immunotherapy to allow for a strong understanding of the current requirements and obligations in the development of immunotherapy products.
- Increasing patient compliance and increasing the quality of life for the patients that are being treated on a day to day basis with therapeutics.
- Personalised medicines for the treatment of specific phenotypes rather than taking the one fits all strategy.
- New pathways will be discussed and elaborated to allow for new targeting strategies to be developed.
Join us and hear expert opinions on these and many more topics in the field of Allergy therapeutics.
Benefits of Attending
- Discussing recent breakthroughs in the field of allergy therapeutics
- Ultra-Fast Desensitisation
- Understanding why it is important to make vaccines immunogenic for the correct responses
- Standardisation and Regulation in immunotherapy products: What’s new?
- Paediatric randomised clinical trials for allergy therapeutics
- Development of Allergenoid therapeutics.
Plus Two Half-Day Pre-Conference Workshops | Tuesday 7th July 2015
A: Tear Biomarkers for Ocular AllergyWorkshop leader: Dr Virginina Calder, Senior Lecturer, ORBIT, Institute of Ophthalmology, UCL
8.30am - 12.20pm
B: Improving probability of success in allergy clinical trialsWorkshop leaders: Dr Juan Gispert, European Head Allergy, Respiratory, Infectious Diseases, Vaccines Medical Science & Strategy, Quintiles and Vivienne McDonald Director, Site and Patient Networks, Site and Patient Networks, Quintiles
1.30pm - 5.45pm
Speakers
- Adam Chaker, Munich Allergy Research Centre, Klinikum rechts der Isar, Technische Universität München
- Angelika Sager, Medical Director, Leti Laboratories
- Anne Marie Salapatek, President & Chief Scientific Officer, Inflamax Research, Inc.
- Clare Lloyd, Professor of Respiratory Immunology, Imperial College London
- Diderik Boot, Medical Director, HAL-Allergy
- Guy Scadding, Specialist registrar, Royal Brompton Hospital
- Ian Strickland, Research Scientist, MedImmune
- Inmaculada Cerecedo, Medical Advisor, Laboratorios Leti
- Juan Gispert, Senior medical director. European Head Allergy, Respiratory, Infectious Diseases and Vaccines, Quintiles
- Kate Rochlin, CSO, Immunovent
- Lucie Mondoulet, Director of Research Department, DBV Technologies
- Lynne Regent, CEO, Anaphylaxis Campaign
- Lynne Regent, Chief Executive Officer, anaphylaxis campagne
- Philip Ashton-Rickardt, Professor of Immunology, Imperial College London
- Rod Hafner, Senior Vice President Research and Development, Circassia Ltd
- Tim Higenbottam, Research & Development Director, Allergy Therapeutics Ltd
- Tracy Hussell, Centre Director MCCIR, Manchester University
- Virginia Calder, Senior Lecturer, UCL
Please fill in your name and email to receive the conference agenda of this event.
The agenda is available as PDF under downloads at the right side of the page.
Venue
The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.
Who Should Attend
This event is aimed at Chief Executives, Chief Scientific Officers, Presidents, Senior Vice Presidents, Vice Presidents, Heads, Senior Directors, Directors, Clinicians, Principal Scientists, Research Fellows, Principal Investigators, Managers, Project/Team Leaders in:
- Immunotherapy Drug Discovery
- Allergy Medicine
- Allergy Pharmacology
- Immunotherapy
- Research Immunology
- Pharmacology
- Immunotherapy Licensing
- Inflammation and Autoimmunity
- Immunology
- Allergy Cell Biology
- Allergy Therapeutics
- Allergy Devices
- Medical Devices
- Inflammation Discovery
- Allergy Medicine Regulation
Venue
Marriott Hotel, Regents Park128 King Henry's Road
London, NW3 3ST
United Kingdom
